References
- ArunachalamRSadehNMThe supply chain trading agent competitionElectronic Commerce Research & Applications200541638110.1016/j.elerap.2004.10.010
- BalciOOrmsbyWFConceptual modeling for designing large-scale simulationsJournal of Simulation20071317518610.1057/palgrave.jos.4250023
- Barbuceanu M, Teigen R and Fox MS (1997). Agent based design and simulation of supply chain systems. Proceedings of the Workshop on Enabling Technologies: Infrastructure for Collaborative Enterprises, IEEE Computer Society Press: Los Alamitos, CA, pp 36–42.
- Congressional Budget Office (CBO) (2006). Congress of the United States. Congressional budget office. Research and development in pharmaceutical industry. Washington: US government printing office, http://www.fdareview.org/approval_process.shtml.
- CockburnIHendersonRScale and scope in drug development: Unpacking the advantages of size in pharmaceutical researchJournal of Health Economics20012061033105710.1016/S0167-6296(01)00108-4
- DanzonPMNicholsonSEpsteinAJMergers and acquisitions in the pharmaceutical industryManagerial and Decision Economics Special Issue: Economic and Policy Issues in the Pharmaceutical Industry2007284–530732810.1002/mde.1343
- DanzonPMNicholsonSPereiraNSProductivity in pharmaceutical–biotechnology R&D: The role of experience and alliancesJournal of Health Economics200524231733910.1016/j.jhealeco.2004.09.006
- DiMasiJAHansenRWGrabowskiHGThe price of innovation: new estimates of drug development costsJournal of Health Economics200322215118510.1016/S0167-6296(02)00126-1
- DiMasiJAHansenRWGrabowskiHGLasagnaLCost of innovation in the pharmaceutical industryJournal of Health Economics199110210714210.1016/0167-6296(91)90001-4
- GrabowskiHGVernonJDiMasiJAReturns on research and development for 1990s new drug introductionsPharmacoEconomics200220Suppl 3112910.2165/00019053-200220003-00002
- GrabowskiHGVernonJMReturns to R&D on new drug introductions in the 1980sJournal of Health Economics199413438340610.1016/0167-6296(94)90010-8
- HendersonRCockburnIScale, scope, and spillovers: Determinants of research productivity in the pharmaceutical industryRAND Journal of Economics1996271325910.2307/2555791
- HigginsMJRodriguezDThe outsourcing of R&D through acquisitions in the pharmaceutical industryJournal of Finance & Economics200680235138310.1016/j.jfineco.2005.04.004
- Pharmaceutical research and manufacturers of America (2006). Pharmaceutical industry profile, http://www.phrma.org/files/2006%20Industry%20Profile.pdf.
- RossettiCLHandfieldRBDooleyKForces, trends, and decisions in pharmaceutical supply chain managementInternational Journal of Physician Distribution and Logistics Management2011416607622
- SadehNMTAC’03: A supply chain trading competitionAI Magazine20032418391
- SiebersPAickelinUCeliaHCleggCA multi-agent simulation of retail management practicesProceedings of the 2007 Summer Computer Simulation Conference2007959966
- Solo K and Paich M (2004). A modern simulation approach for pharmaceutical portfolio management. International Conference on Health Sciences Simulation, San Diego, California, USA, http://www.simnexus.com/SimNexus.PharmaPortfolio.pdf.
- SwaminathanJMSmithSFSadehNMModeling supply chain dynamics: A multiagent approachDecision Sciences199829360763210.1111/j.1540-5915.1998.tb01356.x
- WellmanMPGreenwaldAStonePAutonomous Bidding Agents: Strategies and Lessons from the Trading Agent Competition2007
- Yonghui F, Piplani R, de Souza R and Jingru W (2000). Multi-agent enabled modeling and simulation towards collaborative inventory management in supply chains. Simulation Conference Proceedings, Winter 2: 1763, 1771, Vol. 2.